← Eichor
Study identifier: NCT05823376 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Condition: Platelet Recovery After Umbilical Cord Blood Transplantation  ·  Sponsor: Anhui Provincial Hospital

PhaseN/A
Planned participants40
Who can joinAll sexes, 12 Years to no upper limit
Healthy volunteersNo

About this study

To evaluate the efficacy and safety of Avatrombopag for platelet recovery after unrelated cord blood transplantation (UCBT) in patients with bone marrow failure disease

This description comes directly from the study's public registry record.

Talk to the study team

Xiaoyu Zhu, ph.D  ·  15255456091  ·  xiaoyuz@ustc.edu.cn

Aijie Huang, M.D  ·  15221056490  ·  huangaijie@mail.ustc.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)Hefei, Anhui, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05823376